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OBJECTIVES: Cognitive difﬁculties are common among children with neurological 
diseases. A brief-yet-precise screening tool is needed to facilitate timely referral 
for neuropsychological testing in this population. Based on our prior research with 
clinicians, a standardized, self-report measure would be efﬁcient and useful for 
this purpose. This paper reports the development and psychometric properties of a 
pediatric perceived cognitive function item bank (pedsPCF). METHODS: The pedsPCF 
consists of 45 items, developed via children/parent/clinician/teacher interview and lit-
erature review, and were qualitatively evaluated by children/parents and clinicians. 
The calibration sample includes data from 1,497 children: 49% aged 7–12; 45% 13–
17; 6% 18–21. Of them, 56% were males, 16% repeated grades in school, 39% 
received some forms of special education, 30% were given medication for attention 
difﬁculties, and 27% had at least one of the following diagnoses: epilepsy, traumatic 
brain injury, cerebral palsy or brain tumor. Data were randomly divided into two 
datasets to be used for exploratory factor analysis (EFA, n  747) and conﬁrmatory 
factor analysis, speciﬁcally, bi-factor analysis (n  750). The clinical usefulness of 
the pedsPCF was evaluated by determining whether scores could discriminate 
between different sub-groups. RESULTS: One item was deleted due to its low Spear-
man rho and item-scale correlation. Results from the EFA suggested a single factor 
among the remaining 44 items based on a scree plot. Furthermore, all items had 
signiﬁcant loadings (0.3) on the ﬁrst factor after PROMAX rotation. Bi-factor 
analysis supported sufﬁcient unidimensionality with satisfactory ﬁt indices (CFI  
0.923; TLI  0.992; RMSEA  0.112) and all items had signiﬁcantly higher loadings 
onto the general factor versus local factors. T-tests showed that the pedsPCF signiﬁ-
cantly differentiated samples deﬁned by medication use, repeated grades, special 
education status, and neurological diagnosis, all p  0.0001. CONCLUSIONS: The 
initial psychometric properties of pedsPCF are promising. Recruitment for the clinical 
validation study is in progress.
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OBJECTIVES: Although fatigue is increasingly recognized as an important symptom 
in ﬁbromyalgia (FM), qualitative evidence regarding how patients describe this and 
the impact it has on their daily lives is limited. We conducted qualitative research to 
better understand what individuals with FM mean by ‘fatigue’, assessed the impact it 
had on their lives, and developed a conceptual model to represent these ﬁndings. 
METHODS: Open-ended, qualitative interviews were conducted with 40 FM patients 
(US (n  20), Germany (n  10) and France (n  10)) using open-ended questions and 
creative tasks to elicit unbiased information about FM and FM fatigue. Transcripts 
were analysed using qualitative methods based on grounded theory. RESULTS: 
Participants were 70% female; mean age 48.7 years (range 25–79) with a range of 
education levels. Thirty-one (77.5%) spontaneously described experiencing fatigue/
tiredness/lack of energy due to FM. The conceptual model developed depicts key ele-
ments of FM fatigue from a patient perspective, which was discussed as being more 
severe than normal tiredness, constant/persistent and unpredictable. In the model it is 
deﬁned as: an overwhelming feeling of tiredness (n  17, 42.5%), not relieved by 
resting/sleeping (n  14, 35%), not proportional to effort exerted (n  25, 62.5%), 
associated with a heavy feeling in their body (n  16, 40%) or a weak feeling in their 
muscles (n  9, 22.5%), makes it difﬁcult to motivate themselves to do things (n  
23, 57.5%), affects things they want to do (n  27, 67.5%), or makes tasks take longer 
to do (n  15, 37.5%), and makes it difﬁcult to concentrate (n  21, 52.5%), think 
clearly (n  12, 30%) or remember things (n  9, 22.5%). CONCLUSIONS: The 
majority of individuals with FM experience fatigue and describe how it is more severe 
than normal tiredness. The qualitative data supported development of a conceptual 
model of key elements of FM fatigue from the patient perspective which will be used 
to construct an FM speciﬁc fatigue measure.
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BACKGROUND: Many Health-Related Quality-of-Life (HRQOL) and Patient-
Reported Outcomes (PRO) instruments are scored by averaging or summing Likert-
category values over all items or domains of the elicitation instrument, yielding 
domain-speciﬁc scores or a total score for the entire instrument. OBJECTIVES: To 
review the evidence on whether linear scoring algorithms in HRQOL/PRO instruments 
are consistent with patient preferences in asthma, oncology, and obesity. METHODS: 
Three studies used similar methods to adapt the Onset-of-Effect Questionnaire (OEQ), 
the European Organisation for Research and Treatment of Cancer Quality of Life 
Questionnaire-C30 (EORTC QLQ-C30), and the Impact of Weight on Quality of Life 
Questionnaire-Lite Version (IWQOL-Lite) to choice-format conjoint surveys. In each 
study, the researchers used the domains and categories of a HRQOL/PRO instrument 
to determine the attributes and levels for the conjoint surveys. They applied similar 
choice-modeling approaches to estimate the relative importance of health outcomes 
assessed by each of the three HRQOL/PRO instruments. RESULTS: For each 
HRQOL/PRO instrument, the domains were not equally important to patients and 
improvements in adjacent categories were not equally important within and across 
domains. In particular, the asthma and oncology study results indicated that patient 
preferences for the health outcomes were strongly non-linear. Overall, there were sta-
tistically signiﬁcant and clinically meaningful divergences between the relative impor-
tance to patients of individual domains and categories and the linear, additive 
assumptions required by scoring algorithms. CONCLUSIONS: Conjoint methods 
provide a practical means for eliciting preference-based scoring weights for HRQOL/
PRO domains. The results provide an alternative to the conventional linear scoring 
approach that reﬂect underlying preference non-linearities and variability in impor-
tance of domains.
PODIUM SESSION III: VACCINES – MODELING STUDIES
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OBJECTIVES: Despite widespread immunization programs, a clear increase in pertus-
sis incidence is apparent in many developed countries during the last decades. Conse-
quently, additional immunization strategies are considered to reduce the burden of 
disease. This study aims at designing an individually-based dynamic model to estimate 
the cost-effectiveness of adolescent pertussis booster vaccination in The Netherlands. 
METHODS: We designed a discrete event simulation (DES) model to predict the 
 epidemiological and economic consequences of implementing universal adolescent 
vaccination. We used national age-speciﬁc notiﬁcation data over the period 1996–
2000 -corrected for underreporting- to calibrate the model assuming a steady state 
situation. Thereafter adolescent vaccination was introduced. Other input parameters 
of the DES-model were obtained from literature and, if not available, from expert 
opinions (e.g. on waning immunity). Subsequently, medical unit costs from national 
guidelines were attached to pertussis-related resource use and linked to the epidemio-
logical outcomes. As there is no consensus on the duration of immunity acquired by 
natural infection, we considered two scenarios that differed in duration of protection 
(i.e. 8y and 15y). RESULTS: Although the steady state situation resulted in different 
ratios of symptomatic versus asymptomatic cases (0.10:0.90 and 0.17:0.83 in the 
whole population for the 15- and 8-year scenario respectively), the total incidence 
decreased in the whole population as a result of adolescent vaccination in both sce-
narios. From a societal perspective the cost-effectiveness was estimated at a4418/
QALY (range: 3205–6364 a per QALY) and a6371/QALY (range: a4139–9549 per 
QALY) for the 8-year and 15-year protection scenarios respectively. Sensitivity analy-
ses revealed that the outcomes are most sensitive to the quality of life weights used 
for pertussis disease. CONCLUSIONS: To our knowledge we designed the ﬁrst indi-
vidually-based dynamic framework to model pertussis transmission in the population. 
This study indicates that adolescent pertussis vaccination is likely to be a cost-effective 
intervention for The Netherlands.
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OBJECTIVES: To build an inﬂuenza cost-effectiveness model, combining a population 
based compartmental inﬂuenza transmission model with a standard cost-effectiveness 
analysis. METHODS: Transmission dynamics are simulated using a system of linked 
differential equations. The population is compartmentalised into those who are sus-
ceptible to infection, those exposed (infected) but not infectious, those who are infec-
tious and those who are recovered and immune due to infection or vaccination. 
RESULTS: Antigenic drift is simulated using a published approach and assuming that 
immune individuals lose immunity and become susceptible at a constant rate (different 
for inﬂuenza A and B). Latent and infectious periods of two days are assumed. Age-
speciﬁc mortality rates and annual birth rates are incorporated, consistent with a 
realistic age structure. Age-dependent population mixing patterns are captured in a 
‘Who Acquired Infection from Whom’ matrix. The transmission coefﬁcient is adjusted 
to obtain a good simulation ﬁt with actual data. A sine function simulates seasonal 
variation, giving a peak that is 1.43 times its mean value, resulting in a 2-year inter-
epidemic period, for each A subtype (H1N1/H3N2). These are out of phase, so an A 
type epidemic occurs annually. Duration of protection in the model is 6 years and 12 
years for inﬂuenza A and B, respectively, supporting a good ﬁt with actual transmis-
sion data and a 2-year inter-epidemic period. Cost-effectiveness component is linked 
to the simulated portion of the population that is symptomatic using age stratiﬁed 
resource use information attributable to inﬂuenza illness. CONCLUSIONS: The 
